{"name":"Biophytis","slug":"biophytis","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BIO101","genericName":"BIO101","slug":"bio101","indication":"Amyotrophic lateral sclerosis (ALS)","status":"phase_2"}]}],"pipeline":[{"name":"BIO101","genericName":"BIO101","slug":"bio101","phase":"phase_2","mechanism":"BIO101 is a small molecule targeting the SARM1 protein to prevent mitochondrial dysfunction.","indications":["Amyotrophic lateral sclerosis (ALS)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQSHNudWFIYlZxaGhINDNkemRUYzRKbVYwaW1qWkhFeXFYeUVkSFFVaWI1NjNMM05oWFBSbFRodF9Gck96cms3NmJlVVVQX01KRTFnS2M4eHNON3lyT3F5TWZTT3lqNUxKYnE0NUVnUXdWM2pZV2FzTzhSRkFybWFEYjZoMXVMR1p0R3FpQ3ZzR0F2SVBkMUlrVVV2NzM2ZUJRU01kMF9pRFhZT1Y3UC04bDRsV1l3MkpYQlN3YzlvMUtIMDd4ZkxLQXFiUDJGdHZYLXRiVjJvMGVUdw?oc=5","date":"2026-04-01","type":"pipeline","source":"Barchart.com","summary":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQNlE3bTBfVnBMamswdXc5VkZtazEzLTRwZEI2XzM1M3lEMzA0MTM5UEFrdlIxR3pEUnJybnNFVzJiRlZNMktMbVplNzBibGIxOTg3a0V1bG4zeGt3dlV0bV9nVko2S0tuY1RSN2VhLWM2ODcwc0JJR0VwczdrcmtDb2wxTnp2aHlIMUNfWkFLdDJfVGdncVVTQXlxM0tNNUJObDJBdTE5YXZlVGZldHJXdW1TbktadjFwUGxqUG13VlUwbGh4NEtB?oc=5","date":"2026-03-19","type":"pipeline","source":"Idéal Investisseur","summary":"Biophytis Shares Drop Over 90% in a Year, Reaching a Critical Threshold - Idéal Investisseur","headline":"Biophytis Shares Drop Over 90% in a Year, Reaching a Critical Threshold - Idéal Investisseur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQMENOZVhsd3BRMGtLTzh3Y3U3WV9KZlVHZ1dsWjFhOFdtdVcxMXc1Vnk4bWh3ellvMi1RbnFVcEhteVc5V0x0bEkwUXF5aHVUQk4zeVMtNjB0Qkpxa3ZsS3B5QUxUa1hJWk93UEJRbXkweXlIUUVFM2FWdkRERWpmN2xRaGptY3VuakJDdUg5WQ?oc=5","date":"2026-03-16","type":"pipeline","source":"Yahoo Finance","summary":"Biophytis and LynxKite expand alliance to boost AI-driven drug discovery - Yahoo Finance","headline":"Biophytis and LynxKite expand alliance to boost AI-driven drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxNcExXbDRXdE1YUnpjU1pBS0UxeTdfb25MRWRWTjF5Q2ZkVGZqZ0hUckt4cmt5clVQaUZpVHQ5dnBYMzl0SDRfTEItdTZyc0lLVlA0VzdlZ2Eyc0ZOVHVqd0dETjNyaVNobkJBbGZldnhCYUE2R3VLS1ZyRWZMUUxHdjBMbTJTYzl2aFdBVXkwdjZrclVFMW55cU84SExpMEpLUm9wNHhWcHVUcjBMZEs1cXFJWXprYm9nV0pnbkJyVGlLc3ZFc2tmQW9RbndjRC1RY1VXaEZPUHBYMnUwWnhkd213ZWlOaHJRM3llY1BKOFlDSUQ1WjdFWTNKcGhoTlFxWnlsV3FtRlFSazlsS29palVfWWp2TDNNOENaR09YelpKMDVCbnR3M3VON1dNVmt3RkI0eVJ6U21wRE0xUzhrWFk4b3VpUFlMdjJOQ1BMbEFrREE?oc=5","date":"2026-01-23","type":"regulatory","source":"Barchart.com","summary":"Stargardt Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Nanoscope Therapeutics, Belite Bio, Biophytis, reVision Therapeutics - B","headline":"Stargardt Disease Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveIn","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQbFVfYXRKSUJJaVJMSnAzdDBkaVU0eTFPUDBuWnkzVF9BbDNhOFZvU0JhYmIwcFhFSmZlcXE1Z2NLOU9sS0JtSWhJU0QtQnMxRE9nUmFELUdNQVpxRzZkSGFNQ1JHLU8zZkdKWWE4RjV0LTBxcjdvRURwT1ZvRTRjY1pFSV9QaGw1YWJzeHdEUGxYdw?oc=5","date":"2025-04-24","type":"trial","source":"Yahoo Finance","summary":"Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Yahoo Finance","headline":"Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Seg","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxORk1xb1hTbjNwTHJ2VC13UW5DT0xIOUFySW9EbE1WbjhmNFBLMkZIcHlkLXZJOWtXanFnMnowd1dtZGVDOHI5Zms2VHhMNUVVUlNpN0FQU0VEQks3czM5MzBqd2x6NTZPSXpXQWxudkhsQWtpRVBUeUtrQnVBb0YyTkR4WkJYbkxYclNidmxGTUZsUFkwRjl6QjMtVnFvYmo4NGVqZ1RBU0c1S3dOZl93QUpCbzBWQk5tTXo4dnl3UVktQ2xrdHY4MjktVUg4Yk11SjdCX2pTZjh2Mks4Rk5aaTFVV0dHOVJNbjc0TjUxTGNmd0gteGFBUWhXU1JwdE5ZWTZZcUEtbHR2QzdrcTVLelJQMnBINm8?oc=5","date":"2024-09-25","type":"pipeline","source":"GlobeNewswire","summary":"Sarcopenia Market Anticipates Impressive Growth Trajectory - GlobeNewswire","headline":"Sarcopenia Market Anticipates Impressive Growth Trajectory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeVNYaWFCQkdsdnZNSFpSeTBDY2NQTmk5bDQ3U3puZmYxZUdVYV83OFJxTTB2dFlybVR4NDNRWjNqVnJJQ3loaWFMWnBodW0za2dnVTFqV2Mtal9OYUFvN0pzVkRXdUpSSWNod1NVWUU4VzlWdEhaV2dOWUFaNFJoZUhfQUQ1Q25i?oc=5","date":"2024-04-09","type":"pipeline","source":"InvestorPlace","summary":"Why Is Vincerx Pharma (VINC) Stock Down 64% Today? - InvestorPlace","headline":"Why Is Vincerx Pharma (VINC) Stock Down 64% Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5uZklINnJ5QzQzUldOakFXY202a3pVUkZldGtZS0lxVkJ0d3JVSUpPeHF3aWdyQUxhYS1VUHpJUno2OXBXYlVvQ3NvOTVNaVVVbkl2NHBwOG10NWF3aDFr?oc=5","date":"2023-11-25","type":"pipeline","source":"TradingView","summary":"BPBS Stock Warrant Price and Chart — EURONEXT:BPBS - TradingView","headline":"BPBS Stock Warrant Price and Chart — EURONEXT:BPBS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNUklNdm1UZDV5bWFQUXFURWgzU2o3S2FNMm9pakluN0M0X0hCbmdHcGYtQlpUd1BHN1o4NkMzSFpJVU5SVXlGTXZPZ0RPM01jcU94UnRJeDZvV0pjSnJxLXdKYzA4MDdIRTAxNlM0RGlzLTJlMWZac0t4blV2Z21UUF9IQ1VMbmYzZE50NDVtSQ?oc=5","date":"2023-07-10","type":"regulatory","source":"Clinical Trials Arena","summary":"Biophytis files for FDA authorisation for first Phase III sarcopenia study - Clinical Trials Arena","headline":"Biophytis files for FDA authorisation for first Phase III sarcopenia study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPUUFxUGFpOVFIRGhqR00tR1B2bnQ1MGpWYkc2NWtBYWx5Q0lpZm9BT2RqMTFRUUJId21oRk13WHhRLVJOWnd1WFI2bVM2UTZZQTctazh0RTFNNGtyT2RtUmFQSWsxdkdXdzlhZFU2aDd1RnR5UnktVDRTa3ZHTjFDVnE2VUZJN2Zjd3pBWTlnMGVFTXhyLXdDUGVpSUJSQy1wenplakhJQ0FFejNO?oc=5","date":"2022-12-01","type":"trial","source":"Investing.com India","summary":"U.S. shares higher at close of trade; Dow Jones Industrial Average up 2.18% - Investing.com India","headline":"U.S. shares higher at close of trade; Dow Jones Industrial Average up 2.18%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE44OEo1MW5FY1BXeS1MWFdzMUYyNFFoOG10cVRvSkloaU9QUWpKNEJxWHU2Zm5icUpOZnVLYWNzOWszbWJpaEI0WjFDWGFjUQ?oc=5","date":"2021-02-10","type":"pipeline","source":"Stock Titan","summary":"Latest BPTS News - Biophytis Publishes First-Half Financial Re... - Stock Titan","headline":"Latest BPTS News - Biophytis Publishes First-Half Financial Re...","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}